Tongyan Liu
Peking University(CN)Second Hospital of Shandong University(CN)Jiangsu Cancer Hospital(CN)Zhejiang University-University of Edinburgh Institute(CN)Zhejiang University(CN)Nanjing Medical University(CN)Northeastern University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy(2019)864 cited
- → Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes(2015)364 cited
- → Biomarkers for cancer-associated fibroblasts(2020)309 cited
- → Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma(2022)172 cited
- → FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice(2016)131 cited
- → Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway(2016)104 cited